OptiShot ultra-compliant balloon enables tissue contact and precise anatomic delivery of pulsed energy for treatment of atrial fibrillation in first European patients MARLBOROUGH, Mass.--(BUSINESS ...

Investigators evaluated the incidence of asymptomatic cerebral emboli and cognitive outcomes in patients receiving pulsed field ablation for AF.

The FDA approved the first pulsed field ablation (PFA) catheter, the PulseSelect PFA system, for the treatment of paroxysmal and persistent atrial fibrillation (Afib), Medtronic announced on Wednesday ...

MIAMI--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, today announced the late-breaking ...

IRVINE, Calif., Feb. 2, 2024 /PRNewswire/ -- Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi, announced 12-month results from the company ...

HAYWARD, Calif., April 23, 2025--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) ...

On Monday, the U.S. Food and Drug Administration (FDA) approved Abbott Laboratories’ (NYSE: ABT) Volt PFA System to treat patients battling atrial fibrillation (AFib). AFib is the most common type of ...

The pulsed-field ablation (PFA) market is fierce. However, Boston Scientific hopes to gain an advantage with the new Farawave Nav Ablation Catheter. The Marlborough, MA-based company announced it won ...

The newer, supposedly safer atrial fibrillation (Afib) ablation systems had safety issues of their own, researchers reported based on multicenter registry data. From several hundred cases starting in ...

Boston Scientific, Abbott and Medtronic all presented successful readouts of their cardiac devices during the Heart Rhythm Society’s (HRS) 2026 annual meeting. Medtronic presented new, late-breaking ...